No evidence of harms of probiotic lactobacillus rhamnosus gg atcc 53103 in healthy elderly—a phase i open label study to assess safety, tolerability and cytokine responses

HIGHLIGHTS

  • who: Botelho C and collaborators from the Editor:, Universidade do Extremo Sul Catarinense, Brazil have published the paper: No Evidence of Harms of Probiotic Lactobacillus rhamnosus GG ATCC 53103 in Healthy Elderly—A Phase I Open Label Study to Assess Safety, Tolerability and Cytokine Responses, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0113456]. December 1, 2014 of January/19,/2011
  • what: The aim of this open label clinical trial is to assess the safety and of colony forming units (CFU) of LGG administered orally twice daily to elderly volunteers for days.
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?